Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05337410 · ClinicalTrials.gov registry record · NA
YES: Innovative Discussion for Engagement, Achievement, and Service
A NA study of Violence Prevention, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 512
- Enrollment target
- 1
- Study location
NCT05337410: Recruiting NA study of Violence Prevention, sponsored by University of Michigan.
NCT05337410 is a NA study of Violence Prevention that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 512 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05337410, a NA study of Violence Prevention, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 512 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the efficacy of YES-IDEAS (YES: Innovative Discussion for Engagement, Achievement, and Service)compared to regular after school programming in increasing youth empowerment, promoting positive behaviors, and decreasing youth violence. Through the evidence-based YES (Youth Empowerment Solutions) program, youth design and implement projects to help improve their communities. In the current study, investigators adapted the existing YES curriculum to empower youth from diverse backgrounds to reduce violent behavior. The adapted curriculum, YES-IDEAS, focus on middle school students. The investigators test the effects of YES-IDEAS curriculum on youths' sense of empowerment, attitudes, and violent behavior. They designed the study to be a group-randomized trial in after-school programs across multiple middle schools in south-east Michigan, but issues that arose due to the COVID-19 pandemic and other practical issues with the schools we modified the design to be a matched control group design at the school level. Matching variables included size, geographic locations, race/ethnicity, free/reduced lunch status. Dose-response and sustainability of YES-IDEAS effects are also examined.
Primary Outcome
6 items on a 4 point Likert scale ranging from 1 (never) to 4 (3 or more times) assess the frequency of physical violence perpetration in the past 30 days. A sample item is "In the past 30 days, how often have you hit someone with your fists or beat up someone?" A higher score indicates more instances of violence perpetration in the past 30 days. Items were adapted for the current study from Hurd et al. (2011).
Conditions Studied
Interventions
- BEHAVIORAL YES IDEAS
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What NCT05337410 shows while recruiting
NCT05337410 is an interventional study that assigns participants to a tested intervention. The registered 512 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Violence Prevention appearing as the primary indexed condition, and to 1 intervention - of which YES IDEAS is the first listed.
NCT05337410 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05337410 about?
NCT05337410 is a clinical study titled "YES: Innovative Discussion for Engagement, Achievement, and Service". The purpose of this study is to evaluate the efficacy of YES-IDEAS (YES: Innovative Discussion for Engagement, Achievement, and Service)compared to regular after school programming in increasing youth empowerment, promoting positive behaviors, and decreasing youth violence. Through the evidence-bas...
What is the current status of trial NCT05337410?
This trial is currently recruiting. It is a NA study. The enrollment target is 512 participants. The study started on 2022-04-01. Estimated completion is 2026-11-30.
What conditions does trial NCT05337410 study?
This clinical trial studies the following conditions: Violence Prevention.
What interventions are being tested in trial NCT05337410?
The interventions under investigation include: YES IDEAS (BEHAVIORAL).
Who is sponsoring clinical trial NCT05337410?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05337410 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05337410's enrollment target sits among peer trials
512 192nd of 2000 higher than 1,809 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
- NCT06096259 · 512 participants · Phase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- NCT06585488 · 514 participants · Phase 1
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI